Sepsis

Sugar-binding protein galectin-1 could be a biomarker for patients at risk of life threatening sepsis

Groundbreaking method uses biomarkers to detect sepsis two to three days before the first clinical symptoms appear

Availability of results within five to six hours of blood draw allows faster and more precise intervention

CHOP researchers developed computational tool aided by the CHOP Research Institute's Arcus Pediatric Knowledge Network

Recent study provides high quality evidence that, in patients with septic shock, the combination of high dose intravenous vitamin C, thiamine, and hydrocortisone is not superior to usual care with hydrocortisone alone

Even if sepsis doesn't kill its victims, it can create lifelong disabilities in survivors

Recent research has potential implications for the diagnosis and treatment of this life-threatening condition

Investigators develop advanced technology that can measure white blood cell activation and function, providing significantly more prognostic information about patients with sepsis

Early consultation with an ID specialist associated with 40 percent lower mortality